2 completed. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Reflex Sympathetic Dystrophy: new trials by email Literature Review of Reflex Sympathetic Dystrophy trials Research Report on Reflex Sympathetic Dystrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I Placebo, Neridronic acid 62.5 mg - Complex Regional Pain Syndrome, Type I | Phase 2 / Phase 3 | Completed | Grünenthal GmbH | 459 | 2015-04-01 | 2018-05-09 |
| Pain Exposure Physical Therapy (PEPT) Versus CBO in Patients With Complex Regional Pain Syndrome Type I (CRPS-1) PEPT, CBO standard - Complex Regional Pain Syndrome, Type I | Phase 2 / Phase 3 | Completed | Radboud University Medical Center | 62 | 2009-01-01 | 2013-07-24 |
Complex Regional Pain Syndromes (1)
Autonomic Nervous System Diseases (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Peripheral Nervous System Diseases (2) · Complex Regional Pain Syndromes (1)
1,10-phenanthroline-platinum(II)-ethylenediamine (1) · 6-amino-1-hydroxyhexane-1,1-diphosphonate (1)
Grünenthal GmbH (1) · Radboud University Medical Center (1)
Germany (1) · Netherlands (1) · United Kingdom (1) · United States (1)
PMID 22515496, PMID 25919011, PMID 26628523
2014 (1)